Hongbin Liu

Title: Innovations by Hongbin Liu in Medicinal Chemistry

Introduction

Hongbin Liu, an accomplished inventor based in Kunming, China, has made significant contributions to the field of medicinal chemistry. With a focus on innovative pharmaceutical compounds, Liu's work aims to address critical health issues, particularly those related to mood disorders.

Latest Patents

Liu holds a patent for a novel polymorph of triaryldimethylpiperazine dihydrochloride. The patent, titled "Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof," describes five distinct polymorphic forms B, P, F, J, and O of the compound. These forms are explored for their preparation methods and applications in creating medications to prevent or treat mood disorders and diseases associated with the δ opioid receptor.

Career Highlights

Currently, Hongbin Liu is associated with the Yunnan Institute of Materia Medica, where he has been instrumental in researching and developing effective pharmaceutical solutions. His dedication to innovation in drug formulation and delivery systems has positioned him as a key figure in his field, resulting in enhanced therapeutic outcomes for patients.

Collaborations

Throughout his career, Liu has collaborated with notable professionals, including Jingkun Wang and Zhaoyun Zhu. These partnerships have fostered a creative environment for research and development, leading to breakthroughs in medicinal chemistry and the advancement of new therapeutic agents.

Conclusion

Hongbin Liu's innovative work exemplifies the impact that dedicated inventors can have on the healthcare industry. His patent on polymorphs of triaryldimethylpiperazine dihydrochloride not only sheds light on novel preparation methods but also holds promise for addressing mood disorders effectively. Liu's contributions signify a commitment to progress and excellence in the field of medicinal chemistry.